Literature DB >> 25126267

Why Financial Incentives Aren't Enough to Move the Needle on Compliance.

Emily Cox1.   

Abstract

Year:  2009        PMID： 25126267      PMCID： PMC4106587     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  5 in total

1.  Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.

Authors:  Douglas E Mager; Emily R Cox
Journal:  Am J Manag Care       Date:  2007-06       Impact factor: 2.229

2.  Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.

Authors:  Kavita V Nair; Kerri Miller; Joseph Saseen; Pamela Wolfe; Richard Read Allen; Jinhee Park
Journal:  Am Health Drug Benefits       Date:  2009-01

3.  The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Authors:  William H Shrank; Tuyen Hoang; Susan L Ettner; Peter A Glassman; Kavita Nair; Dee DeLapp; June Dirstine; Jerry Avorn; Steven M Asch
Journal:  Arch Intern Med       Date:  2006-02-13

4.  Lowering copayments: impact of simvastatin patent expiration on patient adherence.

Authors:  Rebecca L Sedjo; Emily R Cox
Journal:  Am J Manag Care       Date:  2008-12       Impact factor: 2.229

Review 5.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

Authors:  Dana P Goldman; Geoffrey F Joyce; Yuhui Zheng
Journal:  JAMA       Date:  2007-07-04       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.